BlackRock Fund Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $51.8M | Buy |
2,309,648
+251,317
| +12% | +$5.64M | 0.01% | 1664 |
|
|
2016
Q3 | $46.7M | Buy |
2,058,331
+109,789
| +6% | +$2.49M | 0.01% | 1625 |
|
|
2016
Q2 | $46M | Sell |
1,948,542
-36,578
| -2% | -$863K | 0.01% | 1554 |
|
|
2016
Q1 | $40.5M | Buy |
1,985,120
+82,609
| +4% | +$1.69M | 0.01% | 1578 |
|
|
2015
Q4 | $97.9M | Buy |
1,902,511
+130
| +0% | +$6.69K | 0.02% | 981 |
|
|
2015
Q3 | $81.1M | Buy |
1,902,381
+104,668
| +6% | +$4.46M | 0.02% | 1061 |
|
|
2015
Q2 | $81.9M | Sell |
1,797,713
-2,901
| -0.2% | -$132K | 0.02% | 1159 |
|
|
2015
Q1 | $68.4M | Buy |
1,800,614
+125,966
| +8% | +$4.78M | 0.02% | 1288 |
|
|
2014
Q4 | $47.4M | Buy |
1,674,648
+376,728
| +29% | +$10.7M | 0.01% | 1498 |
|
|
2014
Q3 | $32.8M | Sell |
1,297,920
-1,403
| -0.1% | -$35.5K | 0.01% | 1638 |
|
|
2014
Q2 | $37.9M | Buy |
1,299,323
+543,086
| +72% | +$15.8M | 0.01% | 1589 |
|
|
2014
Q1 | $19.6M | Buy |
756,237
+32,278
| +4% | +$836K | 0.01% | 2007 |
|
|
2013
Q4 | $18.6M | Buy |
723,959
+474,878
| +191% | +$12.2M | 0.01% | 2028 |
|
|
2013
Q3 | $6.66M | Buy |
249,081
+29,713
| +14% | +$795K | ﹤0.01% | 2602 |
|
|
2013
Q2 | $5.39M | Buy |
+219,368
| New | +$5.39M | ﹤0.01% | 2640 |
|